These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 20525143)
1. Role of genetic polymorphisms in therapeutic response to anti-asthma therapy. Oppenheimer J Allergy Asthma Clin Immunol; 2007 Jun; 3(2):50-2. PubMed ID: 20525143 [TBL] [Abstract][Full Text] [Related]
2. Variable therapeutic response in asthma: a genetic perspective. Bhatnagar P; Guleria R; Kukreti R Per Med; 2006 Feb; 3(1):61-78. PubMed ID: 29783436 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of response to asthma controller therapy: clinical implications. Langmack EL; Martin RJ Curr Opin Pulm Med; 2010 Jan; 16(1):13-8. PubMed ID: 19875959 [TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetics of treatment with leukotriene modifiers. Wechsler ME; Israel E Curr Opin Allergy Clin Immunol; 2002 Oct; 2(5):395-401. PubMed ID: 12582322 [TBL] [Abstract][Full Text] [Related]
7. The pharmacogenetics of asthma therapy. Tantisira KG; Weiss ST Curr Drug Targets; 2006 Dec; 7(12):1697-708. PubMed ID: 17168844 [TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Single Nucleotide Polymorphisms in Diagnosis of Asthma and its Subtypes. Park JS; Son JH; Park CS; Chang HS Yonsei Med J; 2019 Jan; 60(1):1-9. PubMed ID: 30554485 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of anti-inflammatory treatment in children with asthma: rationale and design of the PACMAN cohort. Koster ES; Raaijmakers JA; Koppelman GH; Postma DS; van der Ent CK; Koenderman L; Bracke M; Maitland-van der Zee AH Pharmacogenomics; 2009 Aug; 10(8):1351-61. PubMed ID: 19663678 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic Changes in Asthma: Role of DNA CpG Methylation. Bae DJ; Jun JA; Chang HS; Park JS; Park CS Tuberc Respir Dis (Seoul); 2020 Jan; 83(1):1-13. PubMed ID: 31905427 [TBL] [Abstract][Full Text] [Related]
12. Managing asthma in the 21st century: role of pharmacogenetics. Wechsler ME Pediatr Ann; 2006 Sep; 35(9):660-2, 664-9. PubMed ID: 16999299 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic approaches to asthma treatment. Cho SH Allergy Asthma Immunol Res; 2010 Jul; 2(3):177-82. PubMed ID: 20592916 [TBL] [Abstract][Full Text] [Related]
14. The pharmacogenetics of asthma: an update. Tantisira KG; Weiss ST Curr Opin Mol Ther; 2005 Jun; 7(3):209-17. PubMed ID: 15977417 [TBL] [Abstract][Full Text] [Related]
15. Potential genetic influences on the response to asthma treatment. Pelaia G; Vatrella A; Gallelli L; Cazzola M; Maselli R; Marsico SA Pulm Pharmacol Ther; 2004; 17(5):253-61. PubMed ID: 15477120 [TBL] [Abstract][Full Text] [Related]
16. Genetic profiling and tailored therapy in asthma: are we there yet? Lugogo NL; Ginsburg GS; Que LG Curr Opin Mol Ther; 2007 Dec; 9(6):528-37. PubMed ID: 18041663 [TBL] [Abstract][Full Text] [Related]
17. Genetic diversity of the IL-4, IL-4 receptor and IL-13 loci in mestizos in the general population and in patients with asthma from three subpopulations in Mexico. López KI; Martínez SE; Moguel MC; Romero LT; Figueroa CS; Pacheco GV; Ibarra B; Corona JS Int J Immunogenet; 2007 Feb; 34(1):27-33. PubMed ID: 17284225 [TBL] [Abstract][Full Text] [Related]
19. The significance of beta2-adrenergic receptor polymorphisms in asthma. Litonjua AA Curr Opin Pulm Med; 2006 Jan; 12(1):12-7. PubMed ID: 16357573 [TBL] [Abstract][Full Text] [Related]
20. What are the alternatives to increasing inhaled corticosteroids for the long term control of asthma? Flood-Page P; Barnes NC BioDrugs; 2001; 15(3):185-98. PubMed ID: 11437684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]